Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Yes, your logic makes sense.
It’s pretty incredible that another 32%+ share of the US market have adopted Miri’s technology in the last 2 months. Those that haven’t will be watching very closely or signing up too, so perhaps more news on further penetration.
I’ll use this quiet time to accumulate.
Thanks for your input & quick responses btw.
So it’s clear that the market is waiting to see what sort of revenues will be attributable to this content.
What do you think 🤔 2Phevs?
How soon will we get an indication on initial revenue streams and from that, extrapolate potential?
Very interesting, thanks.
Crikey, you couldn’t make it up.
The market is currently putting pretty much zero value on what Miri have developed & the penetration they’ve achieved in the biggest market in the World, I mean, The US was built on advertising.
I’ve bought a chunk to get me started, but I think I’ll look at a much bigger holding in the ISA.
Thank you 2Phevs, great input & knowledge.
I think once our seller is done this will start a pretty magnificent northward trajectory, these micro-caps can be hard to fathom, and accumulating a large position takes confidence, but the time to do it is when the stock is depressed.
I’ve seen this situation on a number of occasions, investors shun the stock as it doesn’t move, whatever news is being released to the market, and then, suddenly, whoosh, off it goes, and the majority are thinking, ‘why didn’t I buy loads more at that level?’
Remember, they’ve spent hundreds of millions developing this, and it’s about to rollout across the USA with Medicare.
Christopher Mills has 10M shares and paid 90p for his last tranche, look him up, he’s in the business of lending money.
Mount Sinai May be the bidder as the already hold 15% of the stock.
Going to get very interesting, the stock was over £15.00 ( $34.00USD) so let’s see how much someone is prepared to offer.
I have no doubts that this is going to be a very popular product, whether one suffers from diagnosed ED, or not.
Apart from the ED market, There are numerous occasions whereby perfectly young & healthy men have erection issues, stress, overtired, ‘stage fright’ with a new partner, too much alcohol etc etc.
Having some gel handy, aswell as a condom or 2, will become the norm.
In regards to the reviews, The NHS has approved the product for prescription, so it has already undergone strict approval processes proving its effectiveness.
My interest at this stage is how much FUM is going to be worth within 6, 12, 18 months time?
If annual sales accelerate and Eroxon takes a minimum of 20% of the Global market (£4.7Bn) then consider our MCap then.
Personally, being able to buy OTC & use a product like Eroxon, that works within 10 minutes, without side effects, will Trump products that take an hour, such as Viagra, with a number of well documented side effects, plus an interview before one can purchase it.
So, I consider our market will gain increasing traction and eventual sales will be phenomenal.